NICE recommends Loncastuximab tesirine for DLBCL
New third line treatment available for relapsed or refractory diffuse large B-cell lymphoma.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
New third line treatment available for relapsed or refractory diffuse large B-cell lymphoma.
Read the stories of others affected by lymphoma.
Our magazine, Lymphoma Matters, keeps you updated.
A unique opportunity to hear from experts and meet others affected by lymphoma.
A new video with Dr Rob Lown.
Seren, diagnosed with Hodgkin lymphoma, talks about the challenges of getting a diagnosis.
Mike and Kasia share their experience of skin lymphoma.
Help us become finalists in the Smiley Charity Film Awards 2024!
A reflection on our policy work over the past year, and our plans for 2024 when representing the issues faced by people affected by lymphoma.